Expanded Access: Past, Present and Future Improvements
Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning
Expanded access is a program that provides patients with investigational medicinal products (IMP) for treatment purposes. These patients are often excluded from clinical trials but could still benefit from access to the drugs, biologics or medical devices being tested. While, in concept, expanded access represents a way to help more patients receive new and developing treatments, in reality, the process is complex and often misunderstood.
Related Education Resources.
All Resources2023 EKF Workshop - Getting Clinical Trial Supplies a Seat at the Table
Topics: EKF - 2023, Project Management
Presentation
Members
Lessons Learned: Conducting COVID Clinical Trials and Building a Clinical Supplies Team During the Peak of the Pandemic
Topics: Conference, COVID-19
Executive Summary
Members
COVID-19’s Impact on the Supply Chain in Asia-Pacific
Topics: COVID-19, Supply Chain
Webinar
Free